New York AG defends shield law against Texas abortion ban challenge, setting up a critical constitutional showdown over telehealth and reproductive rights.
Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
New York AG defends shield law against Texas abortion ban challenge, setting up a critical constitutional showdown over telehealth and reproductive rights.
Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.